A B C D E F G H I J K L M N O P Q R S T U V W X Y Z #

PROSTATE SPECIFIC ANTIGEN, SCREENING

Test Code
LAB578


Alias/See Also
PSA, Screening


CPT Codes
84153

Preferred Specimen
Green top/Gel Li Hep


Minimum Volume
2.0 mL


Transport Temperature
Refrigerated


Methodology
ECLIA

Setup Schedule
Set Up:Daily Report Available:1 day


Reference Range
PROSTATE SPECIFIC ANTIGEN SCREEN: <3.9 ng/mL
The testing method is electrochemiluminescence assay (ECLIA) manufactured by Roche Diagnostics Inc and performed on the Cobas system. Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease.		    


Clinical Significance
PSA testing can have significant value in detecting metastatic or persistent disease in patients following surgical or medical treatment of prostate cancer. Persistent elevation of PSA following treatment or increase in a pretreatment PSA level is indicative of recurrent or residual disease.


Performing Laboratory
GBMC Chemistry



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.